Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden

  title={Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden},
  author={Karam Turk-Adawi and Nizal Sarrafzadegan and I. Fadhil and Kathryn A. Taubert and Masoumeh Sadeghi and Nanette Kass Wenger and Nigel S. Tan and Sherry Lynn Grace},
  journal={Nature Reviews Cardiology},
The Eastern Mediterranean region (EMR) comprises 22 countries or territories spanning from Morocco in the west to Pakistan in the east, and contains a population of almost 600 million people. Like many other developing regions, the burden of disease in the EMR has shifted in the past 30 years from primarily communicable diseases to noncommunicable diseases such as cardiovascular disease (CVD). Cardiovascular mortality in the EMR, mostly attributable to ischaemic heart disease, is expected to… 
Comparison of Cardiac Risk Scores among the East Mediterranean and South Asian Population
Atherosclerotic Cardiovascular Disease (ASCVD) from American College of Cardiology/American Heart Association (ACC/AHA) was found to be significant but the South Asian population needed a population-based tool to assess the accurate CVD risk.
Metabolic health in the Middle East and north Africa.
Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.
Irrespective of composing components, the odds of developing CVD in MetS individuals was higher than in those who did not develop MetS with adjusted odds ratio, which could help in the timely initiation of proper interventions rather than waiting for all MetS components or symptoms of CVD.
The burden of stroke and its attributable risk factors in the Middle East and North Africa region, 1990–2019
The stroke burden has decreased in the MENA region over the last three decades, although there are large inter-country differences, and there was a general negative association between SDI and the burden of stoke from 1990 to 2019.
Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study
IHD is the number one cause of death, disability, and human suffering globally, and age-adjusted rates show a promising decrease, however, health systems have to manage an increasing number of cases due to population aging.
Prevalence of the most frequent risk factors in Iraqi patients with acute myocardial infarction
The findings of this study conclude that AMI occurs in older age and in male gender among Iraqi population, and ST-elevation MI is the main presentation.
Association of Diabetes and Hypertension as risk factors with Ischemic Heart Disease among patients visiting a Public Sector Tertiary Care Hospital of Karachi, Pakistan
IHD occurs more frequently in males of 56-65 years age, with insignificant family history for IHD and diabetes, and is associated with hypertension and diabetes along with sedentary lifestyle, unhealthy diet and smoking/tobacco addiction.
Burden of Ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study
The distribution characteristics of IHD burden provide guidance for decision makers to formulate targeted preventive policies and interventions as well as investigate regional disparities in I HD burden.
Prevalence and incidence of pre-hypertension and hypertension (awareness/control) in Iran: findings from Kerman coronary artery diseases risk factors study 2 (KERCADRS)
The prevalence of pre-HTN decreased but there was no change in the prevalence of HTN during the last 5 years, suggesting that more effective interventions and strategies are needed to reduce deleterious consequences ofHTN.


Coronary artery disease in Africa and the Middle East
The current evidence base suggests that beta-blockers are as effective as other therapies in preventing cardiovascular disease and that concerns relating to their use in hypertension and cardiovascular disease have been overstated.
Coronary Heart Disease in the Middle East and North Africa: Current Status and Future Goals
The growing epidemic of ischemic heart disease in the region led by dramatic increases in incidence of its risk factors will require a multipronged approach to address the varied issues and mitigate the growing prevalence of the disease.
The state of heart disease in Sudan
  • A. Suliman
  • Medicine
    Cardiovascular journal of Africa
  • 2011
The tetrad of hypertension, RHD, IHD and cardiomyopathy constitute the bulk of CVD in Sudan, and Hypertension is prevalent, with poor control rates.
Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study.
Substantially high incidence rates for almost all CVDs and mortality are found and need urgent consideration by health policy makers specifically for women.
Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men
All measures of CAD were strongly predicted by the metabolic syndrome, but that failed to account for the greater prevalence of ECG abnormalities in women than in men.
The Incidence of Coronary Heart Disease and the Population Attributable Fraction of Its Risk Factors in Tehran: A 10-Year Population-Based Cohort Study
Background Data on incidence of coronary heart disease (CHD) is scarce in the Middle East and little is known about the contribution of known risk factors in this area. Methods The incidence of CHD
Prevalence and correlates of coronary heart disease: first population-based study in Lebanon
This first nationwide endeavor conducted in Lebanon to assess the prevalence of coronary heart diseases confirmed the relevance of the classic RFs of CHD and their applicability to the Lebanese population, thus allowing for prevention strategies.
Prevalence and treatment of cardiovascular risk factors in outpatients with atherothrombosis in the Middle East
Patients with atherothrombosis in the Middle East have a high prevalence of risk factors including alarming rates of diabetes mellitus and obesity, and at least one risk factor is uncontrolled in the majority of patients.
Results of the Dyslipidemia International Study (DYSIS)-Middle East: Clinical Perspective on the Prevalence and Characteristics of Lipid Abnormalities in the Setting of Chronic Statin Treatment
Almost two-thirds of statin-treated patients in the United Arab Emirates, Saudi Arabia, Lebanon and Jordan had inadequately controlled lipid levels, suggesting more comprehensive surveillance, awareness and treatment regimens, as well as modification of lifestyle choices, are necessary to halt the rise in cardiovascular disease-related mortality.